Fangbin Weng

The prognostic information of acute kidney injury in patients with decompensated cirrhosis.

Fangbin Weng, 2022, European journal of gastroenterology & hepatology.

Comment on ‘Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus‐related decompensated cirrhosis’

Fangbin Weng, 2021, Journal of viral hepatitis.

Letter: real‐world use of terlipressin in patients with hepatorenal syndrome

Fangbin Weng, 2021, Alimentary pharmacology & therapeutics.

Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis

Yongxin Chen, Xiaofei Li, L. Lou, 2022, Journal of tropical medicine.

Comment on 'Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure'.

Fangbin Weng, 2022, European journal of gastroenterology & hepatology.

Letter to the editor: "Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in Patients With Alcoholic Hepatitis".

L. Lou, Fangbin Weng, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comment on “Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis”

Fangbin Weng, 2021, Clinical and translational gastroenterology.